{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:24:21Z","timestamp":1790882661410,"version":"4.1.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006544","name":"Ministry of Health, State of Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009576","name":"Kenneth Rainin Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018353","name":"European Crohn's and Colitis Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000854","name":"Human Frontier Science Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001735","name":"Weizmann Institute of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020360","name":"Infectious Diseases Society of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005385","name":"Council for Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016982","name":"Rising Tide Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.chom.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:59:49Z","timestamp":1783522789000},"page":"1202-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances and challenges in microbiome transplantation"],"prefix":"10.1016","volume":"34","author":[{"given":"Paromita","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Youngster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhaib K.","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-2110","authenticated-orcid":false,"given":"Eran","family":"Elinav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib2","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1073\/pnas.1019378108","article-title":"Microbiota regulates immune defense against respiratory tract influenza A virus infection","volume":"108","author":"Ichinohe","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41551-021-00749-2","article-title":"Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel","volume":"5","author":"Han","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.chom.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","article-title":"Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT","volume":"174","author":"Suez","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1273861","article-title":"Supplementation with postbiotic from Bifidobacterium Breve BB091109 improves inflammatory status and endocrine function in healthy females: a randomized, double-blind, placebo-controlled, parallel-groups study","volume":"14","author":"Motei","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation ibd","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chom.2025.04.017","article-title":"The microbiome: An actor or stage for the beneficial action of probiotics, prebiotics, synbiotics, and postbiotics?","volume":"33","author":"Sanders","year":"2025","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.gastro.2020.08.041","article-title":"Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain","volume":"160","author":"Rinott","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib12","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"key":"10.1016\/j.chom.2026.06.006_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365548409087145","article-title":"Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces","volume":"16","author":"Schwan","year":"1984","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","article-title":"Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides Difficile Infection","volume":"82","author":"Khanna","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.chom.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-024-02006-7","article-title":"SER-109 (VOWST\u2122): a review in the Prevention of Recurrent Clostridioides difficile Infection","volume":"84","author":"Blair","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.chom.2026.06.006_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12967","article-title":"Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature","volume":"20","author":"Lin","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41591-019-0600-6","article-title":"Vaginal microbiome transplantation in women with intractable bacterial vaginosis","volume":"25","author":"Lev-Sagie","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12016-023-08958-0","article-title":"The Evolving Landscape of Fecal Microbial Transplantation","volume":"65","author":"Shao","year":"2023","journal-title":"Clinic. Rev. Allerg. Immunol."},{"key":"10.1016\/j.chom.2026.06.006_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-025-04186-5","article-title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial","volume":"32","author":"Duttagupta","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib21","series-title":"European consensus conference on faecal microbiota transplantation in clinical practice","article-title":"Gut https:\/\/doi.org\/10.1136\/gutjnl-2016-313017","author":"Cammarota","year":"2017"},{"key":"10.1016\/j.chom.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2017.05.007","article-title":"Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?","volume":"88","author":"Tang","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00077","article-title":"Changes in Microbiota Profiles After Prolonged Frozen Storage of Stool Suspensions","volume":"10","author":"Dorsaz","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0680-9","article-title":"Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection","volume":"14","author":"Youngster","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.chom.2026.06.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104954","article-title":"Delivery routes for faecal microbiota transplants: Available, anticipated and aspired","volume":"159","author":"Gulati","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chom.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.chom.2026.06.006_bib27","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s10620-022-07761-9","article-title":"Delivery of Fecal Material to Terminal Ileum Is Associated with Long-Term Success of Fecal Microbiota Transplantation","volume":"68","author":"Weingarden","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.chom.2026.06.006_bib28","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.cell.2025.05.014","article-title":"Microbiome mismatches from microbiota transplants lead to persistent off-target metabolic and immunomodulatory effects","volume":"188","author":"DeLeon","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-022-00310-2","article-title":"Donor-dependent fecal microbiota transplantation efficacy against necrotizing enterocolitis in preterm pigs","volume":"8","author":"Hui","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.chom.2026.06.006_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1635244","article-title":"Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model","volume":"16","author":"Dai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2026.06.006_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-021-01217-4","article-title":"Development of a rational framework for the therapeutic efficacy of fecal microbiota transplantation for calf diarrhea treatment","volume":"10","author":"Islam","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101034","article-title":"Effects of clinical donor characteristics on the success of faecal microbiota transplantation for patients in Denmark with Clostridioides difficile infection: a single-centre, prospective cohort study","volume":"6","author":"Karmisholt Grosen","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.chom.2026.06.006_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gutjnl-2022-327742","article-title":"Microbial determinants of effective donors in faecal microbiota transplantation for UC","volume":"72","author":"Haifer","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683387","article-title":"An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis","volume":"12","author":"Ponce-Alonso","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2026.06.006_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/gutjnl-2023-329515","article-title":"Revisiting the donor screening protocol of faecal microbiota transplantation (FMT): a systematic review","volume":"73","author":"Ng","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib36","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume":"69","author":"El-Salhy","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib38","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.cell.2024.09.019","article-title":"A core microbiome signature as an indicator of health","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00196","article-title":"Variable Colonization after Reciprocal Fecal Microbiota Transfer between Mice with Low and High Richness Microbiota","volume":"8","author":"Ericsson","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib40","doi-asserted-by":"crossref","first-page":"e00811-21","DOI":"10.1128\/msystems.00811-21","article-title":"Separation of Donor and Recipient Microbial Diversity Allows Determination of Taxonomic and Functional Features of Gut Microbiota Restructuring following Fecal Transplantation","volume":"6","author":"Olekhnovich","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.chom.2026.06.006_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2750","article-title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement","volume":"15","author":"Woodworth","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-022-01251-w","article-title":"Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation","volume":"10","author":"Podlesny","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal Microbiota Transplantation: An Update on Clinical Practice","volume":"52","author":"Kim","year":"2019","journal-title":"Clin. Endosc"},{"key":"10.1016\/j.chom.2026.06.006_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MCG.0000000000001667","article-title":"Predictors of Fecal Microbiota Transplant Failure in Clostridioides difficile Infection: An Updated Meta-analysis","volume":"57","author":"Beran","year":"2023","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.chom.2026.06.006_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S2468-1253(22)00276-X","article-title":"Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Baunwall","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2026.06.006_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.2020067","article-title":"Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D","volume":"14","author":"Singh","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2026.06.006_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10096-025-05278-3","article-title":"Safety and efficacy of fecal microbiota transplantation versus antibiotics for treating clostridioides difficile infection: systematic review and meta-analysis","volume":"45","author":"Bhat","year":"2026","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib48","first-page":"150","article-title":"Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis","volume":"35","author":"Rapoport","year":"2022","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.chom.2026.06.006_bib49","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1093\/cid\/ciaa1486","article-title":"Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant","volume":"72","author":"Zellmer","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib50","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib51","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/bloodadvances.2021005110","article-title":"Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis","volume":"6","author":"Eshel","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.chom.2026.06.006_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-019-1689-y","article-title":"Long-term impact of fecal transplantation in healthy volunteers","volume":"19","author":"Goloshchapov","year":"2019","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib54","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","article-title":"Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial","volume":"29","author":"Routy","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2026.06.006_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2026.06.006_bib57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7326\/ANNALS-24-03285","article-title":"Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection","volume":"178","author":"Juul","year":"2025","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.immuni.2018.12.015","article-title":"Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and ROR\u03b3t+ Regulatory T Cells and Exacerbate Colitis in Mice","volume":"50","author":"Britton","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2026.06.006_bib59","article-title":"The role of fecal microbiota transplantation on the NLRP3-Caspase 1 pathway and anxiety like behavioral in the ulcerative colitis model in rats","volume":"15","author":"Mohammadi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2026.06.006_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients with Ulcerative Colitis: A Randomized Clinical Trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.chom.2026.06.006_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.gastro.2020.07.048","article-title":"A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis","volume":"160","author":"Henn","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib63","article-title":"Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn\u2019s disease complicated with inflammatory mass","volume":"7","author":"He","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2026.06.006_bib64","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/MIB.0000000000000893","article-title":"Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn\u2019s Disease","volume":"22","author":"Vaughn","year":"2016","journal-title":"Inflam. Bowel Dis."},{"key":"10.1016\/j.chom.2026.06.006_bib65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10620-019-05751-y","article-title":"Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn\u2019s Disease","volume":"65","author":"Yang","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.chom.2026.06.006_bib66","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.14309\/ajg.0000000000003196","article-title":"Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn\u2019s Disease","volume":"120","author":"Kao","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.chom.2026.06.006_bib67","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/19490976.2017.1353848","article-title":"The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis","volume":"8","author":"Qazi","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2026.06.006_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202400577","article-title":"Amelioration of Obesity-Related Disorders in High-Fat Diet-Fed C57BL\/6 Mice Following Fecal Microbiota Transplantation From DL-Norvaline-Dosed Mice","volume":"69","author":"Li","year":"2025","journal-title":"Molecular Nutrition Food Res."},{"key":"10.1016\/j.chom.2026.06.006_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.47226","article-title":"Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial","volume":"5","author":"Lahtinen","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.chom.2026.06.006_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.chom.2026.06.006_bib71","doi-asserted-by":"crossref","first-page":"e00120-25","DOI":"10.1128\/aem.00120-25","article-title":"Donor-derived microbial engraftment and gut microbiota shifts associated with weight loss following fecal microbiota transplantation","volume":"91","author":"Ruan","year":"2025","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of Lost Weight and Long-Term Management of Obesity","volume":"102","author":"Hall","year":"2018","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.chom.2026.06.006_bib73","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature20796","article-title":"Persistent microbiome alterations modulate the rate of post-dieting weight regain","volume":"540","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial","volume":"70","author":"De Groot","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1089991","article-title":"Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study","volume":"12","author":"Wu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1500293","article-title":"Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level","volume":"12","author":"Hou","year":"2025","journal-title":"Front. Nutr."},{"key":"10.1016\/j.chom.2026.06.006_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib80","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2017.08.022","article-title":"Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice","volume":"153","author":"Wong","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib81","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib82","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","article-title":"Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer","volume":"358","author":"Bullman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.chom.2026.06.006_bib83","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","article-title":"Commensal Microbiota Promote Lung Cancer Development via \u03b3\u03b4 T Cells","volume":"176","author":"Jin","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chom.2026.06.006_bib85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.chom.2026.06.006_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140940","article-title":"Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma","volume":"5","author":"Limeta","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.chom.2026.06.006_bib87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.chom.2026.06.006_bib88","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.chom.2026.06.006_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-020-00811-2","article-title":"Predictable modulation of cancer treatment outcomes by the gut microbiota","volume":"8","author":"Heshiki","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib90","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-20-1659","article-title":"Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer","volume":"81","author":"Di Modica","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.chom.2026.06.006_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24342-x","article-title":"Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice","volume":"8","author":"Le Bastard","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2026.06.006_bib92","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.62347\/XKUJ3012","article-title":"Updated outcomes and exploratory analysis of RENMIN-215: tislelizumab plus fruquintinib and fecal microbiota transplantation in refractory microsatellite stable metastatic colorectal cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.chom.2026.06.006_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102315","article-title":"Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)","volume":"66","author":"Zhao","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.chom.2026.06.006_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz8926","article-title":"Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients","volume":"12","author":"van Lier","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18127-y","article-title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","volume":"11","author":"Ianiro","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib98","article-title":"Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2026.06.006_bib99","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2022.06.020","article-title":"Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation","volume":"163","author":"El-Salhy","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.chom.2026.06.006_bib101","article-title":"Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2026.06.006_bib102","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","article-title":"Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study","volume":"67","author":"Halkj\u00e6r","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson\u2019s disease\u2014A randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.chom.2026.06.006_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102563","article-title":"Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson\u2019s disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"71","author":"Bruggeman","year":"2024","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.chom.2026.06.006_bib105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.chom.2026.06.006_bib106","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1443-5","article-title":"Potential roles of gut microbiome and metabolites in modulating ALS in mice","volume":"572","author":"Blacher","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib107","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2353396","article-title":"Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis","volume":"16","author":"Yan","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2026.06.006_bib108","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03781-6","article-title":"Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Feng","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.chom.2026.06.006_bib109","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41591-022-01913-0","article-title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation","volume":"28","author":"Schmidt","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib110","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cels.2024.10.007","article-title":"Spatiotemporal dynamics during niche remodeling by super-colonizing microbiota in the mammalian gut","volume":"15","author":"Urtecho","year":"2024","journal-title":"Cell Syst."},{"key":"10.1016\/j.chom.2026.06.006_bib111","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/gutjnl-2018-317842","article-title":"Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection","volume":"68","author":"Mullish","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.chom.2026.06.006_bib112","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1053\/j.gastro.2021.02.013","article-title":"Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation","volume":"160","author":"Fujimoto","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib113","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","article-title":"Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth","volume":"5","author":"Zagato","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1327464","article-title":"Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function","volume":"15","author":"Shang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib115","article-title":"Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07359-8","article-title":"Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells","volume":"9","author":"Burrello","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib117","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2026.06.006_bib118","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpedsurg.2020.02.035","article-title":"Fecal microbiota transplantation by enema reduces intestinal injury in experimental necrotizing enterocolitis","volume":"55","author":"Liu","year":"2020","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.chom.2026.06.006_bib119","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-021-01107-9","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib120","doi-asserted-by":"crossref","first-page":"e00976-25","DOI":"10.1128\/aem.00976-25","article-title":"Fecal microbiota transplantation alleviated heat-induced colonic tissue damage, epithelial apoptosis, and oxidative stress","volume":"91","author":"Liu","year":"2025","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib121","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2575923","article-title":"Design and application of synthetic human gut microbial communities","volume":"17","author":"Kim","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2026.06.006_bib122","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib123","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.chom.2025.02.007","article-title":"A designed synthetic microbiota provides insight to community function in Clostridioides difficile resistance","volume":"33","author":"Tian","year":"2025","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2026.06.006_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-026-04442-2","article-title":"15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial","author":"Bethlehem","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib125","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.cell.2022.08.003","article-title":"Design, construction, and in vivo augmentation of a complex gut microbiome","volume":"185","author":"Cheng","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chom.2026.06.006_bib126","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41586-024-07960-6","article-title":"Commensal consortia decolonize Enterobacteriaceae via ecological control","volume":"633","author":"Furuichi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.chom.2026.06.006_bib127","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2026.06.006_bib128","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S2468-1253(25)00190-6","article-title":"Effects of lyophilised faecal filtrate compared with lyophilised donor stool on Clostridioides difficile recurrence: a multicentre, randomised, double-blinded, non-inferiority trial","volume":"10","author":"Kao","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2026.06.006_bib129","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41396-021-01107-5","article-title":"Fecal filtrate transplantation protects against necrotizing enterocolitis","volume":"16","author":"Brunse","year":"2022","journal-title":"ISME J."},{"key":"10.1016\/j.chom.2026.06.006_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49152-w","article-title":"Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice","volume":"15","author":"Mao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-41329-z","article-title":"Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety","volume":"14","author":"Wortelboer","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06103-6","article-title":"Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection","volume":"9","author":"Zuo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib133","article-title":"Donation strain engraftment demonstrates feasibility of vaginal microbiota transplantation to prevent recurrent bacterial vaginosis","author":"Hussain","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.chom.2026.06.006_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102070","article-title":"Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study","volume":"61","author":"Wr\u00f8nding","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.chom.2026.06.006_bib135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib136","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-021-01062-5","article-title":"Challenges in exploring and manipulating the human skin microbiome","volume":"9","author":"Boxberger","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib137","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.csbj.2021.01.001","article-title":"Skin microbiome transplantation and manipulation: Current state of the art","volume":"19","author":"Callewaert","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.chom.2026.06.006_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226857","article-title":"Transfer of skin microbiota between two dissimilar autologous microenvironments: A pilot study","volume":"14","author":"Perin","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2026.06.006_bib139","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120608","article-title":"First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis","volume":"3","author":"Myles","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.chom.2026.06.006_bib141","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86955","article-title":"Transplantation of human skin microbiota in models of atopic dermatitis","volume":"1","author":"Myles","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.chom.2026.06.006_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12091797","article-title":"Oral Microbiome: A Review of Its Impact on Oral and Systemic Health","volume":"12","author":"Rajasekaran","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.chom.2026.06.006_bib143","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41579-023-00963-6","article-title":"The oral microbiome: diversity, biogeography and human health","volume":"22","author":"Baker","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2026.06.006_bib144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPH.0000000000002896","article-title":"Safety, Feasibility, and Advantages of Oral Microbiota Transplantation: The First Clinical Case","volume":"46","author":"Goloshchapov","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.chom.2026.06.006_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-62752-4","article-title":"Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up","volume":"16","author":"Wilson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2026.06.006_bib146","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-020-0792-5","article-title":"Fecal microbiota transplantation to maintain remission in Crohn\u2019s disease: A pilot randomized controlled study","volume":"8","author":"Sokol","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2026.06.006_bib147","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: A multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.chom.2026.06.006_bib148","article-title":"Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics","volume":"3","author":"Podlesny","year":"2022","journal-title":"Med."},{"key":"10.1016\/j.chom.2026.06.006_bib149","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2026.06.006_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1451356","article-title":"Protective effect of gut microbiota restored by fecal microbiota transplantation in a sepsis model in juvenile mice","volume":"15","author":"Han","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2026.06.006_bib151","article-title":"Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312826002660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312826002660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:51:31Z","timestamp":1785880291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312826002660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":151,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1931312826002660"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2026.06.006","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and challenges in microbiome transplantation","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}